Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Total Non-current Assets
All assets not expected to be converted to cash within one year.
Vivani Medical, Inc.NASDAQ: VANI
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets broadly unchanged from a year ago
Total non-current assets stood at $20.81M at the end of Q1 FY2026, up 1.0% from a year earlier and down 3.2% from the prior quarter. Over 3 fiscal years it compounded at +81.4% a year.
Context
- Total non-current assets amounted to 49.1% of total assets at the end of Q1 FY2026, down 9.0 pp from a year earlier.
- Total non-current assets increased in 2 of the last 3 fiscal years.
What to watch
Whether total non-current assets keeps rising in the next quarterly balance sheet after a +1.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 21.5M USD
- Year-over-year change
- +1.8%
- 4-year CAGR
- +63.8%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.5M | +1.8% |
| FY2024 | 2024-12-31 | 21.12M | -7.1% |
| FY2023 | 2023-12-31 | 22.74M | +531.2% |
| FY2022 | 2022-12-31 | 3.6M | +20.7% |
| FY2021 | 2021-12-31 | 2.98M | — |
Total Non-current Assets vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +1.0% is the 4th highest of 8, against a peer median of -3.5%.
- Total non-current assets amounts to 49.1% of total assets for VANI, versus a peer median of 10.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $200.7M USD | +1149.4% | +178.2% | 74.7% | |
| Mar 2026 | $71.22M USD | -3.5% | -3.6% | 32.5% | |
| Mar 2026 | $20.81M USD | +1.0% | +81.4% | 49.1% | |
| Mar 2026 | $19.9M USD | -7.8% | +24.6% | 38.6% | |
IMAImageneBio Inc | Mar 2026 | $14.68M USD | +6.0% | +1.2% | 10.7% |
| Mar 2026 | $4.31M USD | -13.4% | -6.9% | 7.1% | |
| Mar 2026 | $1.54M USD | +551.7% | +33.5% | 2.0% | |
| Mar 2026 | CA$139.33K CAD | -23.7% | -35.3% | 0.4% | |
| Peer median (excluding VANI) | — | -3.5% | +1.2% | 10.7% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.